Sustained clinical benefit, improved quality of life, and reduced intestinal surgery from maintenance infliximab treatment in inflammatory bowel disease-Reference-Cited by-同舟云学术

Sustained clinical benefit, improved quality of life, and reduced intestinal surgery from maintenance infliximab treatment in inflammatory bowel disease

Published:2020-02-01 Issue:2 Volume:55 Page:178-183
ISSN:0036-5521
Container-title:Scandinavian Journal of Gastroenterology
language:en
Short-container-title:Scandinavian Journal of Gastroenterology

Author:

Hossain Akter¹²,Lördal Mikael³,Olsson Annika E.²,Storlåhls Anette²,Aleman Soo²⁴⁵,Eberhardson Michael²⁶,Befrits Ragnar²

Affiliation:

1. Department of Emergency and Reparative Medicine, Karolinska University Hospital, Stockholm, Sweden;

2. Department of Gastroenterology, Karolinska University Hospital, Stockholm, Sweden;

3. Department of Medicine, Division of Gastroenterology and Hepatology, Danderyds Hospital, Stockholm, Sweden;

4. Department of Infectious Diseases, Karolinska University Hospital, Stockholm, Sweden;

5. Department of Medicine Huddinge, Karolinska Institutet, Stockholm, Sweden;

6. Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden

Publisher

Informa UK Limited

Subject

Gastroenterology

Link

https://www.tandfonline.com/doi/pdf/10.1080/00365521.2020.1722738

Reference36 articles.

1. Nationwide prevalence of inflammatory bowel disease in Sweden: a population-based register study

2. Inflammatory Bowel Diseases: Health Care and Costs in Sweden in 1994

3. Annual cost of care for Crohn's disease: a payor perspective

4. The Direct and Indirect Cost Burden of Crohn's Disease and Ulcerative Colitis

5. Costs of Inflammatory Bowel Disease in Germany

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Biologic Therapy for Inflammatory Bowel Disease: Real-World Comparative Effectiveness and Impact of Drug Sequencing in 13 222 Patients within the UK IBD BioResource;Journal of Crohn's and Colitis;2023-12-02

2. Correlation between Treatment Outcomes and Serum Vitamin D Levels As Well As Infliximab Trough Concentration among Chinese Patients with Crohn’s Disease;Gastroenterology Research and Practice;2023-10-06

3. Pathological mechanism and targeted drugs of ulcerative colitis: A review;Medicine;2023-09-15

4. Can we change the natural course of inflammatory bowel disease?;Therapeutic Advances in Gastroenterology;2023-01

5. Will sustained biological therapy improve long‑ term outcome in inflammatory bowel disease?;Polish Archives of Internal Medicine;2022-08-22